“Reviews in Oncology - RIO” is a quarterly, peer-reviewed, open access online journal publishing high quality reviews in all fields of oncology.
Submission is considered on the conditions that papers are previously unpublished, and are not offered simultaneously elsewhere; that all authors have read and approved the content, and all authors have also declared all competing interests; and that the work complies with Ethical Policies of the journal, and has been conducted under internationally accepted ethical standards after relevant ethical review.
This journal employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works
Following publication in RIO, the full-text of each article is deposited immediately and permanently archived in PubMed Central, the US National Library of Medicine's full-text repository of life science literature.
Editorial Policies and Procedures
The journal operates a stringent peer review process.
At the discretion of the Editors, the manuscript may be returned immediately without full review.
Editorial decisions are based not just on technical merit of the work, but also on other factors such as the priority for publication and the relevance to the Journal's general readership. All papers are judged in relation to other submissions currently under consideration.
Human studies should have been approved by an ethics committee but in questionable matters the Editors reserve the right to reject papers. Sources of financial support must be acknowledged. Other kinds of association (such as consultancy, share ownership, or patent-licensing arrangements) should be disclosed to the Editor in a covering letter at the time of submission. Such information will be held in confidence.
Committee on Publication Ethics (COPE)
As a member of the Committee on Publication Ethics (COPE), adherence to the submission criteria stated above is considered essential for publication in Journal of Surgery. Mandatory fields are included in the online submission process to ensure this. If, at a later stage in the submission process or even after publication, a manuscript and/or authors are found to have disregarded these criteria, it is the duty of the Editor to report this to COPE. COPE may recommend that action be taken to inform the authors’ professional regulatory body and/or institution of such a dereliction. The website for COPE may be accessed at: http://www.publicationethics.org.uk
Pre-acceptance English language editing service
Authors for whom English is a second language should have their manuscript professionally edited or edited by a fluent English speaker before submission. This service is aimed to:
• improve grammar, spelling, and punctuation;
• improve clarity and resolve any ambiguity caused by poor phrasing;
• improve word-choice and ensure that the tone of the language is appropriate for an academic journal.
Please contact the Editorial Office if you would like to receive the economic details of such services.
Authors are welcome to submit their papers. There is no set word limit for reviews and there is no need for the abstract to be structured, we suggest to limit reviews to 3.500/4.000 words.
Reviews are divided into narrative/opinion papers, expressing the authors' opinion or organizational matters - sometimes based on some kind of literature search - and systematic reviews on interventions, epidemiology and diagnostics where the guidelines below are to be followed:
a) Statement of type: systematic review with/without meta-analysis
b) A structured abstract (please refer to section below headed 'Structured Abstracts')
• Study design and participants
• Systematic literature search
• Primary and secondary outcomes
• Data extraction
• Data synthesis (e.g. type of meta-analysis)
• Description of included and excluded studies (trials flow diagram)
• Quality assessment of included studies
• Primary and secondary outcomes
• Sensitivity analysis
• Including implications for practice and further research
h) Legends to illustrations
i) Tables and their legends
Systematic reviews and meta-analyses should conform to the PRISMA Statement (http://www.prisma-statement.org/statement.htm), and a checklist and flow diagram should be included in your submission.
References should be cited in the text by number within square brackets and listed at the end of the paper in the order in which they appear in the text. All references must be complete and accurate. If necessary, cite unpublished or personal work in the text but do not include it in the reference list. Where possible the DOI for the reference should be included at the end of the reference. Online citations should include date of access. Use Medline abbreviations for journal names. They can be found at: http://www.ncbi.nlm.nih.gov/sites/entrez?db=journals. References should be listed in the following style:
Sjoholm A, Nystrom T. Inflammation and the etiology of type 2 diabetes. Diabetes Metab Res Rev 2006; 22(1): 4-10.
Boulton AJM, Cavanagh PR, Rayman G. The Foot in Diabetes 4th Edn. John Wiley & Sons: Chichester, 2006; 1- 449.
Upload each figure as a separate file in either .tiff or .eps format, with the figure number and the top of the figure indicated. Compound figures e.g. 1a, b, c should be uploaded as one figure. Tints are not acceptable. Lettering must be of a reasonable size that would still be clearly legible upon reduction, and consistent within each figure and set of figures. Where a key to symbols is required, please include this in the artwork itself, not in the figure legend. All illustrations must be supplied at the correct resolution:
Black and white and colour photos - 300 dpi
Graphs, drawings, etc - 800 dpi preferred; 600 dpi minimum
Combinations of photos and drawings (black and white and colour) - 500 dpi
Tables should be part of the the main document and should be placed after the references. If the table is created in excel the file should be uploaded separately.
Please note that since this journal is published online-only, there are no charges for colour figures.
REM operates an online submission and peer review system that allows authors to submit articles and track their progress online.
Please, submit your review at http://author.rio.it
Copyright and Permissions
Papers become copyright on acceptance for publication. Authors of all manuscripts are required to license copyright in their paper to CIC Edizioni Internazionali s.r.l. Copyright licensing is a condition of publication. Accepted papers will not be passed to the Publisher unless copyright has been licensed.
A completed Exclusive Licence Form must be sent by email (as a scanned attachment), fax or post to the Editorial Office:
Reviews in Oncology
CIC Edizioni Internazionali
Corso Trieste 42
k.a. Marilena Cefa
phone +39 06 8412673
fax + 39 06 8412688
Authors must sign, scan and upload to the online system:
For accepted manuscripts the publisher will supply proofs to the submitting author prior to publication. This stage is to be used only to correct errors that may have been introduced during the production process. Prompt return of the corrected proofs, preferably within two days of receipt, will minimise the risk of a delay to publication.
Authority and Responsibility
The intellectual content of the paper is the responsibility of the authors. The Editors and the Publisher accept no responsibility for opinions and statements of authors. While every effort will be made by the Editor and Publisher to avoid inaccurate and misleading data, they accept no liability whatsoever for the consequences of wrong information. The authors agree to keep the Editors and Publisher fully and effectually indemnified against any liability or claims that may arise out of the publication of inaccurate and/or misleading data.